UBS Group AG - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is and the CUSIP is 00430K873. A total of 14 filers reported holding ACASTI PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q1 2023$1,722
-87.7%
3,744
-84.6%
0.00%
Q3 2022$14,000
+1300.0%
24,288
+1944.4%
0.00%
Q1 2022$1,000
-88.9%
1,188
-73.6%
0.00%
Q3 2021$9,0004,5000.00%
Other shareholders
ACASTI PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 27,100$54,0000.01%
TWO SIGMA SECURITIES, LLC 13,370$27,0000.00%
BREWIN DOLPHIN LTD 3$60.00%
Renaissance Technologies 43,408$87,0000.00%
ROYAL BANK OF CANADA 955$2,0000.00%
JANE STREET GROUP, LLC 18,919$38,0000.00%
UBS Group AG 4,500$9,0000.00%
Sargent Bickham Lagudis LLC 5$00.00%
BANK OF AMERICA CORP /DE/ 625$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACASTI PHARMA INC shareholders